【レポートの概要(一部)】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Dementia
06.2 Epidemiology & Forecast (2013-2018)
06.3 Types of Dementia
07. Alzheimer’s Disease
07.1 A Global Burden
07.2 Etiology
07.3 Cost of Care
07.4 Alzheimer’s Disease & Caregiving
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by MOA
09.1.1 AChE Inhibitors
09.1.2 Glutamate Inhibitors
10. Market Assessment of Top Drugs
10.1 Aricept
10.1.1 Sales
10.1.2 Key Regulatory Approvals and Agreements
10.1.3 US Spending by Various Channels 2010-2013
10.2 Exelon
10.2.1 Sales
10.2.2 Key Regulatory Approvals and Agreements
10.2.3 US Spending by Various Channels 2010-2013
10.3 Namenda
10.3.1 Sales
10.3.2 Key Regulatory Approvals and Agreements
10.3.3 US Spending by Various Channels 2010-2013
10.4 Radazyne
10.4.1 Sales
10.4.2 Key Regulatory Approvals and Agreements
11. Competitive Assessment of Top Drugs
12. Focus on Alzheimer’s Research
12.1 National Alzheimer’s Project Act
12.2 Clinical Pipeline
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.2 Market Share Analysis 2013
22. Future Vendors Expected To Tap the Market
23. Key Vendor Analysis
23.1 Eisai Co., Ltd.
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Sales by Geography
23.1.4 Revenue Comparison
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 Forest Laboratories Inc.
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business/Product Segmentation
23.2.4 Product Segmentation by Revenue 2013
23.2.5 Business/Products Segmentation by Revenue 2012 and 2013
23.2.6 Sales by Geography
23.2.7 Business Strategy
23.2.8 Key Information
23.2.9 SWOT Analysis
23.2.10 Strengths
23.2.11 Weaknesses
23.2.12 Opportunities
23.2.13 Threats
23.3 Janssen Pharmaceuticals Inc.
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Business Strategy
23.3.5 Key Information
23.3.6 SWOT Analysis
23.3.7 Strengths
23.3.8 Weaknesses
23.3.9 Opportunities
23.3.10 Threats
23.4 Novartis AG
23.4.1 Key Facts
23.4.2 Business Description
23.4.3 Business Segmentation
23.4.4 Revenue by Business Segmentation
23.4.5 Revenue Comparison 2012 and 2013
23.4.6 Sales by Geography
23.4.7 Business Strategy
23.4.8 Key Developments
23.4.9 SWOT Analysis
23.4.10 Strengths
23.4.11 Weaknesses
23.4.12 Opportunities
23.4.13 Threats
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Projected Prevalence of Dementia by Regions 2013-2050 (in millions)
Exhibit 3: Projected Prevalence of Dementia by Regions 2013-2018 (in millions)
Exhibit 4: Types of Dementia by Prevalence 2013
Exhibit 5: Alzheimer’s Disease and Other Dementias Burden by Geographical Segmentation (Annually) 2013
Exhibit 6: Costs of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias 2013
Exhibit 7: Distribution of Alzheimer’s Caregivers by Age, 2013
Exhibit 8: Projected Prevalence of dependence in 2030 (in percent)
Exhibit 9: Global Alzheimer’s Disease Drugs Market 2013-2018 (US$ billion)
Exhibit 10: Global Alzheimer’s Drugs Market Segmentation by MOA
Exhibit 11: Eisai Co. Ltd.’s Aricept Revenue FY1996-FY2013 (US$ million)
Exhibit 12: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY1996-FY2010 (US$ million)
Exhibit 13: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY2011-FY2013 (US$ million)
Exhibit 14: Key Event Timeline of Aricept Formulations
Exhibit 15: Timeline for Aricept Formulations in US and Europe
Exhibit 16: US Spending on Aricept by Various Channels 2010-2013
Exhibit 17: Novartis AG’s Exelon Revenue 2001-2013 (US$ million)
Exhibit 18: Novartis AG’s Exelon Geography-Wise Revenue 2001-2013 (US$ million)
Exhibit 19: Key Event Timeline of Exelon Formulations
Exhibit 20: US Spending on Exelon by Various Channels 2010-2013
Exhibit 21: Forest’s Namenda Revenue 2004-2014 (FY ending March 2014) (US$ million)
Exhibit 22: Key Event Timeline of Namenda Formulations
Exhibit 23: US Spending on Namenda by Various Channels 2010-2013
Exhibit 24: Razadyne Revenue 2007-2009 (US$ million)
Exhibit 25: Key Event Timeline of Razadyne
Exhibit 26: Sales of Top 3 Alzheimer’s Drugs FY 2004-2013 (US$ million)
Exhibit 27: Sales of Top 3 Alzheimer’s Drugs 2004-2013 (US$ million)
Exhibit 28: Alzheimer’s Disease Research Projects by NIH Institutes and Centers 2011
Exhibit 29: NIH funded Alzheimer’s Disease Research Projects by CADRO topic 2011
Exhibit 30: Classification of Disease Modifying Pipeline Molecules by MOA
Exhibit 31: Clinical Trials of Alzheimer’s Disease by Phase 2013
Exhibit 32: Clinical Trials of Alzheimer’s Disease by Recruitment Status 2013
Exhibit 33: Promising Late Stage Pipeline Molecules 2013
Exhibit 34: Global Alzheimer’s Drugs market by Geographical Segmentation 2013
Exhibit 35: 65+ Global Population 2014-2018 (in million)
Exhibit 36: Global Alzheimer’s Drugs Market Share Analysis 2013
Exhibit 37: Eisai Co., Ltd.: Geographical Segmentation of Revenue for 2013 and 2012(US$ billion)
Exhibit 38: Eisai Co., Ltd.: Revenue comparison for the last 3 years (US$ billion)
Exhibit 39: Eisai Co., Ltd.: Sales by Geography for 2013 (US$ billion)
Exhibit 40: Forest Laboratories Inc.: Product Segmentation (by therapeutic areas) 2013
Exhibit 41: Forest Laboratories Inc.: Product Segmentation by Revenue 2013
Exhibit 42: Forest Laboratories Inc.: Product Segmentation by Revenue 2012 and 2013(US$ million)
Exhibit 43: Company Name: Sales by Geography 2013
Exhibit 44: Janssen Pharmaceuticals, Inc.: Product Segmentation 2013
Exhibit 45: Novartis AG: Business Segmentation
Exhibit 46: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 47: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 48: Novartis AG: Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル:アルツハイマー治療薬のグローバル市場(2014-2018)■ 英文:Global Alzheimer's Drugs Market 2014-2018
■ 発行日:2014年6月20日
■ 調査会社:Technavio
■ 商品コード:IRTNTR3675
■ 調査対象地域:グローバル
- 伸縮性シュリンクフィルムの世界市場分析:樹脂別(リニア低密度ポリエチレン(LLDPE)、低密度ポリエチレン(LDPE)、ポリ塩化ビニル(PVC))副産物(フード、スリーブ、ラベル、ラップ))、用途別(食品・飲料、工業用包装、医薬品、消費財)、セグメント予測、2014 – 2025The global stretch and shrink film market is expected to reach USD 18.46 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for the light-weight material for industrial packaging is expected to drive growth for the product over the forecast period. The demand is expected to be driven by superior packaging properties such as improved printability, easier applicati …
- Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Traditional Wound Management Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Traditional Wound Management market in the BRICS countries. The report provides value ($m), volume (units) and average pr …
- IB1001 (Hemophilia A and B):市場予測と分析(~2022)IB1001 (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
- 変速機用オイルポンプの世界市場2016-2020About Transmission Oil PumpA transmission oil pump is used to circulate oil and maintain volumetric pressure in automatic transmission cars, which is not required in manual cars. The pump helps to build hydraulic pressure and allows other components in the transmission to function properly. It also helps to provide fluid to the transmission cooler and torque converter. Technavio’s analysts forecas …
- ICT予算及び人員配置動向:医療・ヘルスケア産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? Healthcare providers are investing widely in IT hardware and software in 2012. These areas are set to remain the key area of spending amongst healthcare providers in 2013. What are the key drivers behind recent m …
- マイクロプロセッサの世界市場2015-2019About Microprocessors A microprocessor is a processing unit that acts as the brain in electronic devices. Microprocessors are computational semiconductor devices fabricated on a single chip. Over the years, microprocessors have become more powerful, faster, smaller, and affordable. The superior performance of microprocessors has led to their deployment in computers, smartphones, tablets, gaming co …
- 止血弁の世界市場予測(~2023年)“The global hemostasis valves market is projected to register a CAGR of 5.8% during the forecast period.”The market size for hemostasis valves is expected to reach 175 million by 2023 from USD 132 million in 2018, at a CAGR of 5.8%. The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valve …
- クッシング症候群(Cushing’s Syndrome)治療薬の世界市場:コルチコイド受容体拮抗薬、ソマトスタチン類縁体、コルチゾール合成阻害剤About Cushing's Syndrome Cushing's syndrome is a condition caused by the prolonged exposure to very high levels of cortisol. This can occur because of the consumption of glucocorticoid drugs or diseases that result in excess cortisol, ACTH, and CRH secretion. Harvey Cushing described the pathophysiology of this condition in 1932. It is more common in women than in men. Cushing's syndrome is also k …
- ICT予算及び人員配置動向:銀行部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? ICT expenditure is a significant portion of operational spending in the retail banking industry. With business process streamlining a key priority, retail banks are increasing their ICT spending to improve their …
- グローバル画像診断装置(医療機器)メーカー分析(技術能力、戦略、課題):GEThe strategic assessment of GE, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the gl …
- 世界における小型自動車用フロントエンドモジュール市場(2008-2028)This latest just-auto report edition offers a global review of the OE front-end modules sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE 4WD and AWD market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and p …
- Sleep Disorders:グローバル臨床試験レビューH1, 2013Sleep Disorders Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Sleep Disorders Global Clinical Trials Review, H1, 2013" provides data on the Sleep Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sleep Disorders. It includes an overview of the trial numbers and their recruitment status as …
- エンタープライズNAS(ネットワークアタッチトストレージ)の世界市場About enterprise NAS systems NAS systems create a shared file based storage between enterprise users. NAS exists as an independent network node on the LAN and comprises individual IP addresses. File transfer is achieved through Ethernet connections between users and NAS. It facilitates simultaneous access to multiple users. NAS systems can be used as backup storage in enterprises for archiving and …
- 世界の医療産業におけるビックデータ支出市場About big data in healthcare Big data in the healthcare industry refers to a large and complex electronic health data that is difficult to manage with conventional software or hardware or data management tools. Big data in the healthcare industry is tremendous because of its volume, variety, and velocity required to manage it. This includes a wide variety of data ranging from patient data in elect …
- 世界の酪農食品市場動向:企業M&A(2014年5月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global dairy food market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the partne …